Home›Stock Screener›Amwill Health Care

Amwill Health Care Share Price Today | Stock Price & Amwill Health Care Share Screener

AMWILL Pharmaceuticals

Track the current Amwill Health Care share price and stock price live with TickJournal's free stock screener. Check AMWILL 52-week performance for the annual price range and momentum. Use the Amwill Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amwill Health Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹8 and net income of ₹2, with EBITDA of ₹2, an operating margin of 6.0% and a profit margin of 25.0%.

Amwill Health Care Market Cap ₹88.06 Cr.
AMWILL P/E Ratio (TTM) 7.57
Amwill Health Care P/B Ratio 1.07
EPS (TTM) ₹5.71
Dividend Yield 1.16%
Debt to Equity -
AMWILL 52 Week High -
Amwill Health Care 52 Week Low -
Operating Margin 6.00%
Profit Margin 25.00%
AMWILL Revenue (TTM) ₹8.00
EBITDA ₹2.00
Net Income ₹2.00
Total Assets ₹87.00
Total Equity ₹81.00

Amwill Health Care Share Price Chart

Track the current stock price of Amwill Health Care with an interactive chart. Analyse AMWILL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amwill Health Care stock quote in one place.

Amwill Health Care Company Profile - Fundamental Screener

Screen Amwill Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMWILL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0U2L01017.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0U2L01017

Amwill Health Care Balance Sheet Screener

Screen AMWILL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹87, up from ₹72 in 2025.

Latest statistics put total assets at ₹87 and shareholder funds at ₹81.

Item 2026 2025 2024 2023 2022 2021

Assets

Total Assets 87 72 19 12 7 8
Current Assets 72 22 18 11 6 7
Fixed Assets 1 1 1 1 0 1

Liabilities

Total Liabilities 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0

Shareholders' Equity

Total Equity 81 69 17 5 2 -1
Share Capital 20 20 0 0 0 0
Reserves & Surplus 61 49 17 5 2 -1

Amwill Health Care Income Statement Screener - Profit & Revenue Analysis

Screen Amwill Health Care income statement and profit fundamentals. Analyze AMWILL quarterly results. Amwill Health Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹8 and net profit was ₹2, equal to earnings per unit of ₹299.20, at an operating margin of 6%.

In that period expenses were ₹6, interest cost ₹0 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹48 and net profit of ₹11.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March

Revenue and Expenses

Revenue 8 48 41 44 30 28 18
Expenses 6 33 29 27 26 24 19

Operating Costs and Margins

EBITDA 2 16 12 17 4 4 -1
Operating Profit % 6.00% 29.00% 29.00% 38.00% 14.00% 13.00% -6.00%
Depreciation 0 1 1 0 0 0 0
Interest 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 2 15 12 17 4 3 -1
Tax 1 4 1 4 1 1 0
Net Profit 2 11 11 13 3 3 -1
EPS 299.20 5.71 6.63 8.01 2.00 1.65 -0.64

Amwill Health Care Cash Flow Screener - Liquidity Fundamentals

Screen AMWILL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹8, and net cash flow was an inflow of ₹14.

Over the same period, investing activities provided ₹6 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March

Cash from Operations and Investing

Operating Activities 8 6 -3 5 3 0
Investing Activities 6 -46 -1 -1 0 -1

Financing and Net Cash

Financing Activities 0 41 0 0 0 0
Net Cash Flow 14 1 -5 3 3 -1

Amwill Health Care Shareholding Pattern Screener

See Amwill Health Care shareholding pattern with promoter, FII, and DII holdings. Check Amwill Health Care promoter holding and ownership changes for AMWILL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 70.65%, foreign institutions 0.00%, domestic institutions 0.00% and the public 26.37%, spread across 1,483 shareholders.

The shareholder count was 1,483 in 2026-Mar, compared with 1,606 in 2025-Sept.

Item 2026-Mar 2025-Sept 2025-Mar 2025-Feb 2025-Jan 2024-May

Promoter Holding

Promoter Holding 70.65% 70.65% 70.65% 97.00% 97.00% 97.00%

Institutional Investors

FII Holding 0.00% 1.16% 1.16% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 26.37% 24.85% 21.14% 0.00% 0.00% 0.00%
Other Holding 2.98% 3.34% 7.05% 3.00% 3.00% 3.00%
Shareholder Count 1,483 1,606 1,374 7 7 7

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amwill Health Care. Amwill Health Care dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 1.16%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.50 1.16%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Amwill Health Care Stock Index Membership - Nifty & Sensex

See which indices include Amwill Health Care stock. Check AMWILL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 1 indices, including BSE SME IPO.

Complete Index List

BSE SME IPO

Amwill Health Care Market Events Screener - Corporate Actions

Get Amwill Health Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amwill Health Care stock events that may affect AMWILL share price, along with derivatives, futures and options activity and sector gainers.

6 corporate actions are listed, the most recent entry being Annual General Meeting dated August 14, 2026, with a record date of August 14, 2026.

It is followed by Dividend dated August 7, 2026 and Quarterly Result Announcement dated May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-14 2026-08-14 Annual General Meeting NA 1.52%
2026-08-07 2026-08-08 Dividend ₹ 0.50 /share 26.91%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.99%
2025-11-04 2025-11-04 Quarterly Result Announcement NA 6.51%
2025-08-14 2025-08-14 Annual General Meeting NA -6.05%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 0.56%

Amwill Health Care Competitors Screener - Peer Stocks Comparison

Screen AMWILL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 447,476 36.44 61,674 12.69% 11,565 47.42
Divis Laboratories 250,363 86.51 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 186,152 85.91 13,886 20.34% 2,138 48.14
Zydus Life Science 120,798 26.32 27,658 17.64% 5,026 61.81
Cipla 111,426 33.44 29,045 2.24% 3,870 44.03
Laurus Labs 106,838 99.70 6,868 22.01% 890 58.00
Mankind Pharma 105,107 48.73 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 104,492 32.05 35,059 3.90% 4,158 69.59
Aurobindo Pharma 97,682 26.36 34,145 5.56% 3,503 54.69
Lupin 93,829 16.99 29,039 26.75% 5,356 34.02

Amwill Health Care Company Announcements - News & Reports Screener

Screen AMWILL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated October 2, 2026 and August 14, 2026.

Date Update Actions
2026-10-05 Closure of Trading Window -
2026-10-02 Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015 -
2026-08-14 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-14 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-14 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-08 Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015 -
2026-08-08 Announcement under Regulation 30 (LODR)-Change in Management -
2026-07-23 Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015 -
2026-07-23 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-22 Notice Of The Ninth Annual General Meeting For The Financial Year 2025-26 -
2026-07-21 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-17 Disclosure Under Regulation 42 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 -
2026-07-17 Board Meeting Outcome for Outcome Of The Board Meeting Of Board Of Directors Of Amwill Health Care Limited Held On July 172026. -
2026-07-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-19 Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015 -
2026-05-30 SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO") -
2026-05-30 Approval Of Audited Financial Results For Half Year & FY 2026. -
2026-05-30 Announcement under Regulation 30 (LODR)-Dividend Updates -
2026-05-30 Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Meeting Of The Board Of Directors Held On May 30 2026. -
2026-05-28 Compliances-Reg.24(A)-Annual Secretarial Compliance -

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 7.57 and the P/B ratio is 1.07, with earnings per unit of ₹5.71. Market capitalisation stands at ₹88.06 Cr and the dividend yield is 1.16%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 6 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.